Tirzepatide: A novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist for the treatment of type 2 diabetes
2025 Jan 27;26(3):1098
Intravenous administration bypasses the digestive tract, where oral glutathione largely breaks down, so the full dose reaches the blood
To counteract the deleterious effects of the above-mentioned stimuli, the skin has complex defense mechanisms such as: immune and neuroendocrine systems
Make regular follow-up visits so your doctor can monitor your progress and make necessary adjustments to the dosage as needed
Richeldi L, Azuma A, Cottin V, Hesslinger C, Stowasser S, Valenzuela C, Wijsenbeek MS, Zoz DF, Voss F, Maher TM (2022) 13050013 Trial investigators